Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and third
leading cause of cancer-related mortality worldwide. While surgical resection and …

Hepatocellular carcinoma (HCC) is the most common primary cancer of the liver and has an
overall five-year survival rate of less than twenty percent. For patients with unresectable …

Simple Summary Hepatocellular carcinoma (HCC) is the fifth most common cancer
worldwide and the second most common oncological reason for death. Liver resection and …

Liver cancers are the second most frequent cause of global cancer-related mortality of which
90% are attributable to hepatocellular carcinoma (HCC). Despite the advent of screening …

Abstract Purpose and Design Intra-arterial therapies for unresectable hepatocellular
carcinoma (HCC) consist of a catheter-based group of treatments where therapeutic and/or …

Objective This article reviews the current results of various locoregional therapies for
hepatocellular carcinoma (HCC), with special reference to the implications for surgeons …

Locoregional techniques have become the mainstay of therapy for patients with
unresectable hepatocellular carcinoma (HCC). Such image-guided interventions include …

Simple Summary Hepatocellular carcinoma is the most common liver cancer, leading to
approximately 700,000 deaths worldwide and 30,000 deaths in the United States every …

Hepatocellular carcinoma (HCC) represents a significant contributor to cancer-related
morbidity and mortality with increasing incidence in both developing and developed …

Hepatocellular carcinoma (HCC) is one of the most common malignancies in the world,
responsible for an estimated one million deaths annually. It has a poor prognosis due to its …